Source: Annual Congress 2013 –Interesting research questions
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Stavrou, L. Jolly, T. Habgood, A. John, T. Hussel, A. Blanchard, G. Jenkins (Nottingham, Manchester, Stevenage, United Kingdom). Influenza infection affects the degree of fibrosis and apoptosis in the bleomycin mouse model. Eur Respir J 2013; 42: Suppl. 57, 4846

Member's Comments

No comment yet.

Related content which might interest you: Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Olodaterol attenuates bleomycin induced lung fibrosis in mice Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 The immunomodulatory effect of protein S in pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Thymosin beta4 protects mice from bleomycin-induced damage in the lung Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Interaction between mitochondrial ROS and ER stress on PHMG-induced pulmonary fibrosis Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats? Source: International Congress 2016 – ILD pathogenesis Year: 2016 PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced idiopathic pulmonary fibrosis by regulation of extracellular matrix remodelling Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 AAV-Tgfb1 vs. bleomycin: Analysis of gene expression profiles in two models of pulmonary fibrosis Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer Year: 2014 Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Comparison of two murine models of acute and chronic hypersensitivity pneumonitis due to pigeon serum exposure Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 PBI-compound, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: A comparative study with pirfenidone Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Chronic pseudomonas aeruginosa airway infection induces peribronchial lymphoid neogenesis in mice Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Regulation of autophagy in amiodarone induced pulmonary fibrosis Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Targeting the hedgehog/GLI pathway decreases bleomycin-induced lung fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Role of dendritic cells in pulmonary fibrosis in mice Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014